-+ 0.00%
-+ 0.00%
-+ 0.00%

Lake Street Maintains Buy on Immunome, Raises Price Target to $32

Benzinga·12/16/2025 19:22:57
Listen to the news
Lake Street analyst Chad Messer maintains Immunome (NASDAQ:IMNM) with a Buy and raises the price target from $22 to $32.